CSIMarket
 

Thermo Fisher Scientific Inc   (NYSE: TMO)

Thermo Fisher Scientific Inc 's

Competitiveness




 

TMO Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Thermo Fisher Scientific Inc reported Revenue increase in the 2 quarter 2026 by 10.49 % year on year.
The sales growth was above Thermo Fisher Scientific Inc 's competitors' average revenue growth of 8.25 %, achieved in the same quarter.

List of TMO Competitors

With a net margin of 14.52 % Thermo Fisher Scientific Inc reported lower profitability than its competitors.

More on TMO Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Thermo Fisher Scientific Inc Net Income in the 2 quarter 2026 grew year on year by 7.6%, slower than its competitors' income growth of 75.59 %

<<  TMO Stock Performance Comparisons


Thermo Fisher Scientific Inc 's Comment on Competition and Industry Peers


The company operates in industries marked by rapid technological change and frequent new product introductions. Key competitive factors include technological innovation, adoption of emerging technologies such as AI, pricing, service and delivery, product line breadth, customer support, and e-business capabilities. Competitors may respond more quickly to new technologies and customer requirements, potentially gaining cost or quality advantages. The company also competes directly with certain larger customers and product suppliers, which may impact operations if these relationships change. Additionally, the company manufactures products that compete with those sourced from third-party suppliers and procures competitive products from multiple suppliers. Intellectual property challenges and risks related to AI integration are also identified as competitive risks. THERMO FISHER SCIENTIFIC INC. is named as a competitor in company filings.



  

Overall company Market Share Q2 2026

Company's competitiveness improved within Overall company, with revenue growth of 10.49 % and its market share increased to approx. 5.47 %.
<<  More on TMO Market Share.
 
*Market share is calculated based on total revenue.

  News about Thermo Fisher Scientific Inc Contracts

Thermo Fisher Scientific and Flagship Pioneering Join Forces to Revolutionize Life Sciences with First-in-Class Technologies

November 28, 2023

WALTHAM, Mass. and CAMBRIDGE, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific solutions, and Flagship Pioneering, the renowned bioplatform innovation company, have announced an expanded strategic partnership aimed at developing groundbreaking platform companies. Together, they seek to revolutionize the life sciences industry by leveraging novel tools and capabilities that will power the next generation of scientific advancements.
This partnership comes at a crucial time for the industry, with the demand for innovative technologies and solutions skyrocketing. Recognizing this need, Thermo Fisher Scientific and Flagship Pioneering have joined forces to create multiprod...





Publicly Traded Peers of Thermo Fisher Scientific Inc




Azenta Inc
Share Performance



-1.51%
Over The Past 5 Days



Azenta Inc
Profile

Azenta Inc operates under a direct sales business model, where their products are primarily sold through a network of independent distributors. The company focuses on producing and distributing high-quality fragrance products, including perfumes, body sprays, and scented candles. By leveraging a direct sales approach, Azenta Inc aims to build a strong customer base and provide entrepreneurial opportunities for individuals interested in joining their distributor network.

More about Azenta Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,414.595 mill. $ 595.464 mill. $ -178.197 mill.


West Pharmaceutical Services Inc
Share Performance



+37.58%
One Year



West Pharmaceutical Services Inc
Profile

West Pharmaceutical Services Inc operates as a global manufacturer and supplier of innovative packaging and delivery systems for the pharmaceutical and biotech sectors. Their business model focuses on providing comprehensive solutions, including drug administration systems and customer support, to ensure safe and efficient delivery of medications to patients.

More about West Pharmaceutical Services Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 24,867.657 mill. $ 3,326.900 mill. $ 564.900 mill.


Carlisle Companies Incorporated
Share Performance



+2.05%
This Year



Carlisle Companies Incorporated
Profile

Carlisle Companies Incorporated operates as a diversified manufacturing company that supplies a range of products to various industries globally. Its business model is focused on acquiring and integrating companies that manufacture niche products and possess expertise in their respective markets. By leveraging these acquisitions, Carlisle aims to generate consistent revenue growth and enhance its profitability through operational efficiencies and market expansion opportunities.

More about Carlisle Companies Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13,576.005 mill. $ 5,097.000 mill. $ 724.500 mill.


Mettler toledo International Inc
Share Performance



-8.10%
This Year



Mettler toledo International Inc
Profile

Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.

More about Mettler toledo International Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 26,157.098 mill. $ 4,133.875 mill. $ 905.611 mill.


Avantor Inc
Share Performance



+20.39%
One Year



Avantor Inc
Profile

Avantor Inc's business model revolves around providing a wide range of products, services, and solutions to customers in the life sciences, advanced technologies, and applied materials sectors. They focus on delivering a comprehensive offering, including chemicals, lab equipment, consumables, and customized solutions, to support research, development, and production processes.

More about Avantor Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10,030.176 mill. $ 6,552.200 mill. $ -551.400 mill.

103 more competitors available

Sign in to see all competitors

Sources: Thermo Fisher Scientific Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Thermo Fisher Scientific Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.